Stroke

August 13, 2014

New York Xarelto Uncontrollable Bleeding Lawsuit

A Texas woman is the latest to sue Bayer and Johnson & Johnson pharmaceutical companies, claiming that the anticoagulant Xarelto has inadequate warnings about the bleeding risk associated with the drug. Jeanne Jeffcoat filed the lawsuit in the U.S. District Court for the Eastern District of New York, she claimed that Xarelto caused life-threatening bleeding event that left her permanently injured.

There are many defective drug product liability lawsuits filed nationwide over bleeding and hemorrhage side effects of Xarelto.

Xarelto Aggressive Marketing

May 31, 2014

Pradaxa 4,000 Hemorrhage and Death Lawsuits Settles For $650M

by Dr. Shezad Malik

Germany based Boehringer Ingelheim, the manufacturer of the anticoagulant medication Pradaxa has agreed to pay $650 million to settle Pradaxa injury lawsuits. There are 4,000 lawsuits on file by folks who allege that the company failed to warn about the risk of severe and deadly bleeding problems with the anticoagulant drug use.

Pradaxa, has been linked to more than 500 patient deaths. The settlement comes about week after the drugmaker said a new analysis of a company-funded study used to win approval of the Pradaxa found 22 serious bleeding events that weren’t included in the original report.

What is Pradaxa?

April 23, 2014

AndroDerm Stroke Testosterone Patch Lawsuit Filed

by Dr. Shezad Malik

Wesley Davis, from New York filed a stroke product liability lawsuit against Actavis and Watson. Davis alleged that the side effects of the testosterone patch AndroDerm caused him to suffer a serious stroke. Furthermore, Davis claimed that the drug manufacturers failed to warn men about the potential risks associated with use of testosterone replacement therapy (TRT).

What is Androderm?

AndroDerm patch is a low testosterone drug approved by the FDA in 1995 for treatment of low testosterone caused by a medical condition, called hypogonadism. The testosterone replacement therapy medication is delivered in permeable skin patches.

April 15, 2014

Testim Testosterone Gel Louisiana Wrongful Death Lawsuit

by Dr. Shezad Malik

A Louisiana man, who suffered a deadly heart attack, filed a wrongful death lawsuit against Testim gel manufacturer. The lawsuit claims that the 61 year old died as a result of Testim testosterone replacement therapy side effects.

The lawsuit was filed by the family of John Peuler against Auxilium Pharmaceuticals, Inc. on March 21, in the U.S. District Court for the Eastern District of Louisiana. There are close to 100 similar testosterone replacement therapy lawsuits filed across the United States in recent months.

What is Testim?

March 23, 2014

Another AndroGel Heart Attack Lawsuit Filed

by Dr. Shezad Malik

AbbVie, the manufacturer of AndroGel, is exposed to another product liability lawsuit. Kimberly Dula, from Georgia claims that the company failed to warn about the heart risks from AndroGel. Dula claims that he suffered three heart attacks as a result of using the testosterone gel.

49 year old Dula filed the complaint recently in March, in the U.S. District Court for the Northern District of Illinois. There are now several Androgel lawsuits filed throughout the U.S., claiming that the drug manufacturer failed to warn about the risk of heart attacks, strokes, deep vein thrombosis, pulmonary embolism blood clots and wrongful death.

March 10, 2014

California Testosterone Testim Stroke Lawsuit

by Dr. Shezad Malik

A 58-year-old California man who suffered injuries after using the testosterone therapy Testim has sued manufacturer Auxilium Pharmaceuticals Inc., claiming it coordinated a massive ad campaign to aggressively promote the need for its product while failing to warn users of life-threatening side effects.

In a Feb. 26 lawsuit filed in U.S. District Court for the Central District of California, plaintiff Joseph Myers alleges that after taking multiple does of Testim in 2012, he suffered a stroke, which his physicians later informed him was likely caused by the drug.

February 9, 2014

Low T Testosterone Androgel Voodoo Medicine?

by Dr. Shezad Malik

Ten years ago some scientists recruited several hundred volunteers and gave them Testosterone or a placebo. Those taking testosterone got stronger, compared with those taking the placebo, and they could carry a load up stairs faster.

But they also had nearly five times the number of cardiovascular problems, including heart attacks and strokes, and the study ended early.

February 7, 2014

Androgel Heart Attacks Lawsuits Filed in Illinois

by Dr. Shezad Malik

As previously mentioned in this blog, we believe there are serious medical risks from the use of testosterone gel supplements and plaintiffs agree with us. Several recent medical studies have found an increased risk of heart attacks from AndroGel and other testosterone treatments.

The manufacturers of the blockbuster testosterone gel are exposed to a number of lawsuits. This week men who claim injuries from the use of testosterone gels have filed lawsuits.

January 7, 2014

Quack Medicine? Testosterone Gels Is Not Without Major Side Effects

by Dr. Shezad Malik

As a Texas Medical Doctor and a Dallas Dangerous Drug attorney, I am concerned by the onslaught of tv advertisements that specifically target older men. The ads ask the questions with a concerned male voice over, “Have you noticed a recent deterioration of your ability to play sports?” “Do you have a decrease in sex drive?” “Do you have a lack of energy?”

If so, the ads warn, you should “talk to your doctor about whether you have low testosterone” — “Low T,” is the new buzz word.

August 21, 2013

NuvaRing DVT and Pulmonary Embolism Settlement?

by Dr. Shezad Malik

According to Merck company filings, there are now about 1,500 filed product liability lawsuits involving injuries from NuvaRing blood clots. These women claim that the contraceptive ring increased the risk of blood clots, other serious and potentially deadly side effects.

What is Nuvaring?

NuvaRing is a vaginal contraceptive ring, made by Merck’s Organon subsidiary, which is placed in the vagina. The ring releases a combination of estrogen, ethinyl estradiol and the “third generation” progestin, etonogestrel. The ring is replaced every month.